Neuropeptide‐Y Levels in ST‐Segment–Elevation Myocardial Infarction: Relationship With Coronary Microvascular Function, Heart Failure, and Mortality
T Gibbs, N Tapoulal, M Shanmuganathan… - … of the American Heart …, 2022 - Am Heart Assoc
… venous neuropeptide Y that is associated with subsequent heart failure and mortality. …
finding of the present study is that high levels of PV NPY are associated with the development of …
finding of the present study is that high levels of PV NPY are associated with the development of …
Coronary sinus neuropeptide Y levels and adverse outcomes in patients with stable chronic heart failure
OA Ajijola, NA Chatterjee, MJ Gonzales… - JAMA …, 2020 - jamanetwork.com
… neuropeptide Y (NPY). Circulating catecholamines predict risk of death in patients with chronic
heart failure (HF… Neuropeptide Y, which has a longer half-life, is an important modulator of …
heart failure (HF… Neuropeptide Y, which has a longer half-life, is an important modulator of …
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomes
K McDowell, C Adamson, C Jackson… - … of Heart Failure, 2024 - Wiley Online Library
… we found a greater elevation of BNP in individuals with higher NPY levels at baseline. It is
therefore important that in this much larger study with a total of 362 deaths we found an NPY …
therefore important that in this much larger study with a total of 362 deaths we found an NPY …
[HTML][HTML] Relation of plasma neuropeptide-Y with myocardial function and infarct severity in acute ST-elevation myocardial infarction
… associated with microvascular dysfunction after ST-elevation myocardial infarction (STEMI). …
of plasma NPY with myocardial function and infarct severity, visualized by cardiac magnetic …
of plasma NPY with myocardial function and infarct severity, visualized by cardiac magnetic …
Circulating neuropeptide Y may be a biomarker for diagnosing atrial fibrillation
P Wang, J Guo, Y Li, H Liu, X Kang, S Liu, Y Zhang - Cardiology, 2023 - karger.com
… It is more common with increasing age and other diseases, such as coronary artery
disease (CAD), valvular heart disease, heart failure (HF), and damage to kidney function. …
disease (CAD), valvular heart disease, heart failure (HF), and damage to kidney function. …
[HTML][HTML] Neuropeptide Y attenuates cardiac remodeling and deterioration of function following myocardial infarction
YY Qin, XR Huang, J Zhang, W Wu, J Chen, S Wan… - Molecular Therapy, 2022 - cell.com
… Therefore, in the present study, we first characterized the NPY-producing cells in surgically
removed cardiac tissues from patients with chronic heart failure and from mice with AMI. Then…
removed cardiac tissues from patients with chronic heart failure and from mice with AMI. Then…
Neuropeptide Y in patients presenting with acute myocardial infarction
C Libers - 2021 - repozitorij.mefst.unist.hr
… myocardial infarction and lastly as STsegment elevation … of plasma neuropeptide Y and
noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure…
noradrenaline to dynamic exercise and ramipril treatment in patients with congestive heart failure…
Changes in ET-1, Plasma Neuropeptide Y, and CGRP in Child Patients With Congenital Heart Disease Complicated With Pulmonary Hypertension Before and After …
Z Liu, M Zhang, Q Huo, T Zhu - Clinical Pediatrics, 2021 - journals.sagepub.com
… in patients, which is manifested as the elevation of systemic circulation pressure in clinic and
… in patients with congestive heart failure, and different decreasing levels of plasma NPY after …
… in patients with congestive heart failure, and different decreasing levels of plasma NPY after …
The cardiac sympathetic co-transmitter neuropeptide Y is pro-arrhythmic following ST-elevation myocardial infarction despite beta-blockade
… Using the same assay, we have also recently shown in patients with severe heart failure
undergoing implantation of cardiac resynchronization therapy devices, that coronary sinus …
undergoing implantation of cardiac resynchronization therapy devices, that coronary sinus …
[HTML][HTML] Peptide YY (PYY) is associated with cardiovascular risk in patients with acute myocardial infarction
E Haj-Yehia, RW Mertens, F Kahles… - Journal of Clinical …, 2020 - mdpi.com
… with earlier findings of elevated PYY levels in patients with terminal … heart failure, recapitulating
earlier findings of elevated PYY levels in patients with advanced heart failure and cardiac …
earlier findings of elevated PYY levels in patients with advanced heart failure and cardiac …